CCC

CHOKSI LABORATORIES LTD.

No trades
See on Supercharts
Market capitalization
‪412.90 M‬INR
‪32.10 M‬INR
‪344.39 M‬INR
Beta (1Y)
0.83

About CHOKSI LABORATORIES LTD.

CEO
Sunil Kumar Choksi
Headquarters
Indore
Founded
1982
ISIN
INE493D01013
FIGI
BBG000DK8KL4
Choksi Laboratories Ltd. engages in the business of research, development, and analytical testing. It offers a range of laboratory testing services such as pharmaceuticals, food and agricultural products, construction materials, and chemicals. The company was founded in 1982 and is headquartered in Indore, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CHOKSILA is 65.21 INR — it has increased by 4.99% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange CHOKSI LABORATORIES LTD. stocks are traded under the ticker CHOKSILA.
CHOKSILA stock is 4.75% volatile and has beta coefficient of 0.83. Check out the list of the most volatile stocks — is CHOKSI LABORATORIES LTD. there?
Yes, you can track CHOKSI LABORATORIES LTD. financials in yearly and quarterly reports right on TradingView.
CHOKSILA stock has risen by 16.70% compared to the previous week, the month change is a 44.72% rise, over the last year CHOKSI LABORATORIES LTD. has showed a 42.10% increase.
CHOKSILA net income for the last quarter is ‪624.00 K‬ INR, while the quarter before that showed ‪68.00 K‬ INR of net income which accounts for 817.65% change. Track more CHOKSI LABORATORIES LTD. financial stats to get the full picture.
Today CHOKSI LABORATORIES LTD. has the market capitalization of ‪432.61 M‬, it has increased by 5.57% over the last week.
No, CHOKSILA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CHOKSILA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHOKSI LABORATORIES LTD. stock right from TradingView charts — choose your broker and connect to your account.
CHOKSILA reached its all-time high on Jul 25, 2005 with the price of 98.35 INR, and its all-time low was 1.41 INR and was reached on Oct 31, 2003.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHOKSI LABORATORIES LTD. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHOKSI LABORATORIES LTD. stock shows the strong buy signal. See more of CHOKSI LABORATORIES LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHOKSI LABORATORIES LTD. EBITDA is ‪108.37 M‬ INR, and current EBITDA margin is 29.91%. See more stats in CHOKSI LABORATORIES LTD. financial statements.